---
$id: https://graph.org.ai/products/commodity/51313505
$type: Product
source: UNSPSC
code: "51313505"
title: "Dorastine"
class: "51313500"
classTitle: "Antihistamine or H1 blockers, synthesized"
family: "51310000"
familyTitle: "Antihistamines or H1 blockers"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dorastine

**UNSPSC Code**: 51313505
**Class**: [Antihistamine or H1 blockers, synthesized](Antihistamine or H1 blockers, synthesized.mdx)
**Family**: [Antihistamines or H1 blockers](../Antihistamines or H1 blockers.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3087NKH40A. European Medicines Agency schedules Dorastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06370MIG. Dorastine generally arises in the molecular formula C20H22CLN3. The term DORASTINE is an International Non-Proprietary Name or INN. DORASTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dorastine under HS 29333999 and SITC 51574. As of Q4 2014, DORASTINE remains the US FDA Preferred Term for this commodity. Dorastine bears US NLM identifiers UMLS ID C2699801 and NCI Concept Code C76061. SMILES: CLC1CC2C3C(N(C2CC1)CCC1CCC(NC1)C)CCN(C3)C.

